Scarica l'app Stockscreener
79.09
0.40%
-0.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$79.41
Aprire:
$78.57
Volume 24 ore:
329.33K
Relative Volume:
0.57
Capitalizzazione di mercato:
$2.99B
Reddito:
-
Utile/perdita netta:
$-91.00M
Rapporto P/E:
-21.55
EPS:
-3.67
Flusso di cassa netto:
$-74.38M
1 W Prestazione:
-1.54%
1M Prestazione:
-11.85%
6M Prestazione:
+48.75%
1 anno Prestazione:
+26.65%
Intervallo 1D:
$76.91
$80.00
Intervallo di 1 settimana:
$76.24
$80.79
Portata 52W:
$30.82
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Confronta IRON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
79.09 | 3.00B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Ripresa | Stifel | Buy |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-11 | Ripresa | Raymond James | Strong Buy |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus - ts2.tech
Precision Trading with Disc Medicine Inc. (IRON) Risk Zones - Stock Traders Daily
Disc Medicine Earnings Notes - Trefis
Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Disc Medicine (IRON) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Moderna (MRNA) and Disc Medicine (IRON) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), Disc Medicine (IRON) and BioMarin Pharmaceutical (BMRN) - The Globe and Mail
Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy - BioSpace
Avoiding Lag: Real-Time Signals in (IRON) Movement - news.stocktradersdaily.com
Breakouts Watch: Is Disc Medicine Inc. stock attractive for hedge fundsRisk Management & Free Growth Oriented Trading Recommendations - Улправда
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next - ts2.tech
Breakout Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatRisk Management & Technical Confirmation Trade Alerts - Улправда
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Can Disc Medicine Inc. stock deliver consistent earnings growthJuly 2025 Levels & Risk Controlled Swing Trade Alerts - Улправда
Stifel reaffirms Buy rating on Disc Medicine stock amid FDA review speculation - Investing.com Canada
Jefferies reiterates Buy rating on Disc Medicine stock amid FDA concerns - Investing.com Canada
Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’ - Asianet Newsable
Disc Medicine (IRON) Gains Confidence Despite Timeline Concerns - GuruFocus
Disc Medicine stock rating reiterated at Outperform by BMO amid FDA review - Investing.com
Disc Medicine (IRON) Maintains Positive Outlook Amid CNPV Skepti - GuruFocus
Disc Medicine drops on report of FDA skepticism over rare blood disorder drug - TradingView — Track All Markets
Disc Medicine (NASDAQ: IRON) Stock Tumbles on Insider-Selling Headlines as Bitopertin FDA Decision Nears — News, Analyst Forecasts, and What to Watch (Dec. 19, 2025) - ts2.tech
Disc Medicine Enters Oversold Territory (IRON) - Nasdaq
Disc Medicine (IRON) Shares Decline Over 14% - GuruFocus
FDA Fast-Track Review Challenges Impact Disc Medicine's (IRON) B - GuruFocus
Disc Medicine (NASDAQ:IRON) Shares Down 9% After Insider Selling - MarketBeat
How supply chain issues affect Disc Medicine Inc. stockBond Market & Real-Time Volume Spike Alerts - DonanımHaber
Is Disc Medicine Inc. stock a buy before product launchesRate Hike & Expert Approved Momentum Trade Ideas - DonanımHaber
Aug Movers: Why Disc Medicine Inc stock is seen as undervalued2025 Earnings Impact & Capital Efficient Trading Techniques - moha.gov.vn
Why Disc Medicine Inc. stock is seen as undervaluedJuly 2025 Momentum & Reliable Entry Point Alerts - Улправда
Downgrade Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatJuly 2025 Recap & Daily Profit Focused Screening - Улправда
Disc Medicine (NASDAQ:IRON) Director Sells $68,968.38 in Stock - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Short Covering: How analysts rate Disc Medicine Inc. stock todayFed Meeting & Weekly Setup with ROI Potential - Улправда
Hedge Fund Moves: Is Disc Medicine Inc. stock recession proofProduct Launch & Entry Point Confirmation Signals - Улправда
Is Disc Medicine Inc. stock attractive for hedge fundsChart Signals & Precise Swing Trade Entry Alerts - Bollywood Helpline
Disc Medicine Insider Sold Shares Worth $16,858,639, According to a Recent SEC Filing - marketscreener.com
Disc Medicine Insider Sold Shares Worth $1,194,372, According to a Recent SEC Filing - marketscreener.com
Kevin Bitterman Sells 62,693 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine (NASDAQ:IRON) Insider William Jacob Savage Sells 13,093 Shares - MarketBeat
Insider Sell: William Savage Sells 13,093 Shares of Disc Medicine Inc (IRON) - GuruFocus
IRON Receives Updated Overweight Rating and Raised Price Target from Wells Fargo | IRON Stock News - GuruFocus
Disc Medicine (NASDAQ:IRON) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
John Quisel Sells 40,000 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine Insider Sold Shares Worth $3,721,931, According to a Recent SEC Filing - marketscreener.com
Disc Medicine (IRON) CEO reports option exercise and share sale - Stock Titan
Frazier Life Sciences Management L.P. Has $87.64 Million Holdings in Disc Medicine, Inc. $IRON - MarketBeat
This is why Disc Medicine, Inc. (IRON) is a buy on Wall Street - MSN
All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy - MSN
Eventide Asset Management LLC Buys 126,212 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. $IRON Position Lowered by Bain Capital Life Sciences Investors LLC - MarketBeat
Has Disc Medicine’s 2025 Surge Already Gone Too Far After Pipeline Progress Fuels Rally? - Yahoo Finance
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Disc Medicine Inc Azioni (IRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Savage William Jacob | Chief Medical Officer |
Dec 22 '25 |
Option Exercise |
9.97 |
3,143 |
31,350 |
78,845 |
| Quisel John D | Chief Executive Officer |
Dec 19 '25 |
Option Exercise |
1.01 |
12,300 |
12,423 |
184,128 |
| Bitterman Kevin | Director |
Dec 17 '25 |
Sale |
91.47 |
754 |
68,968 |
14,013 |
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):